These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34823399)

  • 1. Analgesic characteristics of a newly developed α
    Komatsu S; Nakamura S; Nonaka T; Yamada T; Yamamoto T
    Mol Pain; 2021; 17():17448069211052167. PubMed ID: 34823399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the
    Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y
    J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of mirogabalin, a novel ligand for α
    Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirogabalin activates the descending noradrenergic system by binding to the α
    Oyama M; Watanabe S; Iwai T; Tanabe M
    J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.
    Domon Y; Kitano Y; Makino M
    Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic effects of the novel α
    Murasawa H; Kobayashi H; Saeki K; Kitano Y
    Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of a new voltage-gated Ca
    Kato J; Inoue T; Yokoyama M; Kuroha M
    Expert Opin Pharmacother; 2021 Dec; 22(17):2311-2322. PubMed ID: 34431423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige
    Kitano Y; Kai K; Yamamura N; Yoshiba S; Kuroha M
    Nihon Yakurigaku Zasshi; 2019; 154(6):352-361. PubMed ID: 31787689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study.
    Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T
    J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation.
    Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y
    Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide W, an endogenous NPBW1 and NPBW2 ligand, produced an analgesic effect via activation of the descending pain modulatory system during a rat formalin test.
    Nakamura S; Nonaka T; Yoshida K; Yamada T; Yamamoto T
    Mol Pain; 2021; 17():1744806921992187. PubMed ID: 33573476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral acetaminophen-induced spinal 5-hydroxytriyptamine release produces analgesic effects in the rat formalin test.
    Nakamura S; Nonaka T; Komatsu S; Yamada T; Yamamoto T
    Biomed Pharmacother; 2022 Feb; 146():112578. PubMed ID: 34959121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirogabalin besylate in the treatment of neuropathic pain.
    Burgess J; Javed S; Frank B; Malik RA; Alam U
    Drugs Today (Barc); 2020 Feb; 56(2):135-149. PubMed ID: 32163529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effects of mirogabalin, a novel ligand for α
    Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y
    Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirogabalin-A Novel Selective Ligand for the α2δ Calcium Channel Subunit.
    Zajączkowska R; Mika J; Leppert W; Kocot-Kępska M; Malec-Milewska M; Wordliczek J
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of mirogabalin, a novel α
    Yamamura N; Uchiyama M; Takahashi M; Honda T; Nishiya Y
    Xenobiotica; 2022 Jan; 52(1):54-64. PubMed ID: 35249464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirogabalin, a novel ligand for α
    Murasawa H; Pawlak A; Kobayashi H; Saeki K; Yasuda SI; Kitano Y
    Biomed Pharmacother; 2021 Jul; 139():111647. PubMed ID: 33940507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of 26RFa, an endogenous ligand for the glutamine RF-amide peptide receptor (QRFP receptor), into the rostral ventromedial medulla (RVM), locus coelureus (LC), and periaqueductal grey (PAG) produces an analgesic effect in rats.
    Yoshida K; Nonaka T; Nakamura S; Araki M; Yamamoto T
    Peptides; 2019 May; 115():1-7. PubMed ID: 30772446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids.
    Tang H; Lu J; Duan Y; Li D
    Mediators Inflamm; 2023; 2023():4893436. PubMed ID: 37152369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of the usefulness of mirogabalin for neuropathic pain: a single-institution retrospective study.
    Kanbayashi Y; Amaya F; Ikoma K; Ueno H; Tabuchi Y; Ishikawa T; Takayama K; Taguchi T
    Pharmazie; 2020 Nov; 75(11):602-605. PubMed ID: 33239138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.